- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2415
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Pilot study of ziv-aflibercept in myopic choroidal neovascularisation patients ; volume:20 ; number:1 ; day:19 ; month:10 ; year:2020 ; pages:1-9 ; date:12.2020
BMC ophthalmology ; 20, Heft 1 (19.10.2020), 1-9, 12.2020
- Creator
-
Nawar, Amin E.
Shafik, Heba M.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12886-020-01679-4
- URN
-
urn:nbn:de:101:1-2020120420082539415826
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:39 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Nawar, Amin E.
- Shafik, Heba M.
- SpringerLink (Online service)
Other Objects (12)
Result of intravitreal aflibercept injection for myopic choroidal neovascularization
Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
Intravitreal ziv-aflibercept in diabetic vitreous hemorrhage
Effect of intravitreal injection of aflibercept or ranibizumab on chorioretinal atrophy in myopic choroidal neovascularization
Retinal vascular changes and aqueous humor cytokines changes after aflibercept intravitreal injection in treatment-naïve myopic choroidal neovascularization
Evaluation of aflibercept and ziv-aflibercept binding affinity to vascular endothelial growth factor, stability and sterility after compounding
Choroidal thickness and choriocapillaris vascular density in myopic anisometropia
Intravitreal aflibercept for active polypoidal choroidal vasculopathy without active polyps
Switching to ziv-aflibercept in resistant diabetic macular edema non responsive to ranibizumab injection
Aflibercept for choroidal neovascularizations secondary to pseudoxanthoma elasticum: a prospective study
Long-Term Outcomes of High-Dose Conbercept Treatment for Myopic Choroidal Neovascularization and Idiopathic Choroidal Neovascularization
Ziv-aflibercept plus pembrolizumab in patients with advanced melanoma resistant to anti-PD-1 treatment
Result of intravitreal aflibercept injection for myopic choroidal neovascularization
Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
Intravitreal ziv-aflibercept in diabetic vitreous hemorrhage
Effect of intravitreal injection of aflibercept or ranibizumab on chorioretinal atrophy in myopic choroidal neovascularization
Retinal vascular changes and aqueous humor cytokines changes after aflibercept intravitreal injection in treatment-naïve myopic choroidal neovascularization
Evaluation of aflibercept and ziv-aflibercept binding affinity to vascular endothelial growth factor, stability and sterility after compounding
Choroidal thickness and choriocapillaris vascular density in myopic anisometropia
Intravitreal aflibercept for active polypoidal choroidal vasculopathy without active polyps
Switching to ziv-aflibercept in resistant diabetic macular edema non responsive to ranibizumab injection
Aflibercept for choroidal neovascularizations secondary to pseudoxanthoma elasticum: a prospective study
Long-Term Outcomes of High-Dose Conbercept Treatment for Myopic Choroidal Neovascularization and Idiopathic Choroidal Neovascularization
Ziv-aflibercept plus pembrolizumab in patients with advanced melanoma resistant to anti-PD-1 treatment
Result of intravitreal aflibercept injection for myopic choroidal neovascularization
Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
Intravitreal ziv-aflibercept in diabetic vitreous hemorrhage
Effect of intravitreal injection of aflibercept or ranibizumab on chorioretinal atrophy in myopic choroidal neovascularization
Retinal vascular changes and aqueous humor cytokines changes after aflibercept intravitreal injection in treatment-naïve myopic choroidal neovascularization
Evaluation of aflibercept and ziv-aflibercept binding affinity to vascular endothelial growth factor, stability and sterility after compounding
Choroidal thickness and choriocapillaris vascular density in myopic anisometropia
Intravitreal aflibercept for active polypoidal choroidal vasculopathy without active polyps
Switching to ziv-aflibercept in resistant diabetic macular edema non responsive to ranibizumab injection
Aflibercept for choroidal neovascularizations secondary to pseudoxanthoma elasticum: a prospective study
Long-Term Outcomes of High-Dose Conbercept Treatment for Myopic Choroidal Neovascularization and Idiopathic Choroidal Neovascularization